MAIA Biotechnology, Inc. (MAIA)
$1.22+6.09%Close
SELLRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $74M
- Beta
- 0.28
- P/E (TTM)
- -1.88
- Short % float
- 3.36%
- Days to cover
- 3.4
- SI change
- +28.2%
- 1W
- +2.52%
- 1M
- -6.87%
- vs SPY 1W
- +1.36%
- vs SPY 1M
- -9.86%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on MAIA?
- LOPJLB’s latest quantitative signal on MAIA Biotechnology, Inc. (MAIA) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is MAIA in?
- MAIA Biotechnology, Inc. (MAIA) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does MAIA Biotechnology, Inc. (MAIA) do?
- MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established …